Jose Ruben Garcia-Montes

Affiliations: 
Cajal Institute, CSIC, Madrid 
Google:
"Jose Garcia-Montes"
Mean distance: 14.65 (cluster 46)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ruiz-DeDiego I, Fasano S, Solís O, et al. (2018) Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin. Scientific Reports. 8: 15381
García-Montes JR, Solís O, Enríquez-Traba J, et al. (2018) Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice. Molecular Neurobiology
Suarez LM, Alberquilla S, García-Montes JR, et al. (2018) Differential synaptic remodeling by dopamine in direct and indirect striatal projection neurons in Pitx3-/- mice, a genetic model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Solís O, García-Montes JR, Garcia-Sanz P, et al. (2017) Human COMT over-expression confers a heightened susceptibility to dyskinesia in mice. Neurobiology of Disease
Solís O, Garcia-Montes JR, González-Granillo A, et al. (2015) Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling. Cerebral Cortex (New York, N.Y. : 1991)
Moratalla R, Khairnar A, Simola N, et al. (2015) Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms. Progress in Neurobiology
Heumann R, Moratalla R, Herrero MT, et al. (2014) Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions. Journal of Neurochemistry. 130: 472-89
García-Montes J, Boronat-García A, Drucker-Colín R. (2012) Pharmacological strategies for Parkinson's disease Health. 2012: 1153-1166
See more...